"The Melanoma and Skin Cancer Institute (MSCI) is a medical oncology practice and research institute specializing in treating patients diagnosed with melanoma and other types of skin cancers via in-person and telehealth consultation."

During the past decade, The Melanoma and Skin Cancer Institute conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Melanoma and Skin Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Melanoma and Skin Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The Melanoma and Skin Cancer Institute" are "Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials) and "Anatomic Stage IIA Breast Cancer AJCC v8" (3 trials). Many other conditions were trialed in "The Melanoma and Skin Cancer Institute" in a lesser frequency.

Most popular intervention types in "The Melanoma and Skin Cancer Institute" are "Drug" (34 trials), "Biological" (30 trials), "Other" (25 trials), "Procedure" (19 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (14 trials), "Computed Tomography" (13 trials), "Quality-of-Life Assessment" (12 trials), "Pembrolizumab" (11 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

The vast majority of trials in "The Melanoma and Skin Cancer Institute" are 41 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "The Melanoma and Skin Cancer Institute". undefined are not yet recruiting, 32 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Melanoma and Skin Cancer Institute, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Melanoma and Skin Cancer Institute, 0 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".